UNSPSC 51441707: Diatrizoate/lidocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DX102. This VA Drug Class (DX102) classifies this compound as belonging to the group IONIC CONTRAST MEDIA.

UNSPSC 51441707 Diatrizoate/lidocaine is a Commodity code whose recent state and local activity shows limited direct relevance to its nominal pharmaceutical scope. The two recent opportunities posted under this code involve X-ray system maintenance services (Broward County Aviation Department) and copper sulfate supply (Pasco County, Florida), neither of which aligns with the injectable contrast agent and anesthetic this code nominally describes. The issuing bodies are a county aviation department and a county purchasing office, both operating as single solicitors in the recent record. State and local governments buying under this code appear to be primarily county-level agencies, though the sparse recent activity limits characterization of repeat buyers or issuing-body patterns.

The recent opportunities cluster in Florida, with Broward County posting an RFI on June 25, 2026 for maintenance services on Rapiscan 600, 900, VOTI XR3D, and Gemini X-ray inspection systems (responses due July 28, 2026), and Pasco County issuing an RFQ on June 3, 2026 for large copper sulfate crystals and liquid copper sulfate on an as-needed basis (proposals due June 26, 2026). The code shows little recent activity aligned with diatrizoate or lidocaine procurement, and the pharmaceutical products nominally represented by this Commodity code do not appear in the recent state and local opportunities available.